Clinical Trial Design and Analysis
Harness next-generation cloud-based study simulation for unique statistical insights supporting earlier decision-making and more successful clinical development.
The KerusCloud® platform has proved to be a core part of our decision-making as it allows us to prospectively tailor study designs as new information becomes available.
Smarter Clinical Trial Design and Analysis with KerusCloud®
KerusCloud® is a powerful clinical trial design and analysis software that enables sponsors to simulate thousands of realistic trial scenarios in silico. By modeling variables such as patient populations, endpoints, recruitment timelines, and estimand strategies, KerusCloud® helps teams identify the optimal design before a trial begins. Fast, data-driven, and cost-effective, it empowers you to reduce risk, accelerate timelines, and increase the likelihood of success.
Using KerusCloud®, our team helps sponsors accelerate development by identifying the right path, first time. Keruscloud® has been seen to increase the probability of success of a single study by 41% and generates more evidence for the same costs. Working in tandem with our clients, we have a track record of de-risking investment through rapid evaluation and testing of assumptions, adding value to current drug pipelines and existing data.
Our design optimization approaches are applied to:
- Target population
- Study Design
- Endpoints
- Analysis Strategy
- Success Criteria
- Selecting the best development strategy
- Choosing between standard or complex innovative design trials such as adaptive platform trials (APTs), seamless studies, basket trials and umbrella trials
- Improving study success rates
- Identifying the best endpoint and patient subgroups
- Generating robust evidence packages for drug approval
- Supporting investment decisions
- Implementing Precision Medicine strategies
- Anonymizing real-world data by generating realistic synthetic data
Transform Traditional Study Design with KerusCloud®
KerusCloud® facilitates informed decision-making by placing statistics at the heart of protocol development, addressing the growing complexity of modern clinical studies.
By incorporating KerusCloud® into the clinical protocol development process information can be leveraged from available data earlier to inform key decisions. This ensures that real clinical studies are comprehensively de-risked and fully optimised in silico at the design stage using its rigorous evidence-based approach.
Suggested For You
news
June 19th, 2025
MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion
perspectives
June 17th, 2025
Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise
regulatory intelligence
June 16th, 2025
Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting
perspectives
June 10th, 2025
Applying Artificial Intelligence (AI) and Real-World Evidence to Boost Efficiency in Patient Safety Narratives
perspectives
June 3rd, 2025
Choosing the Right Strategy: Parallel, Sequential, and Staggered Regulatory Submissions
news
May 28th, 2025
MMS Named Finalist for Fierce CRO Award in Excellence in Client Service and Partnership, CEO shortlisted for the CRO Champion Award
perspectives
May 28th, 2025
A Season of Change: Why the REMS Industry Consortium Matters More Than Ever
perspectives
May 20th, 2025
Navigating FDA OMOR Meetings: A Comprehensive Guide to Type X, Y, and Z Meetings for OTC Drug Sponsors
perspectives
May 6th, 2025
Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn
perspectives
April 24th, 2025
How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy
perspectives
April 8th, 2025
Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements
news
April 3rd, 2025
Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution